Encompass Health Corporation (NYSE: EHC) has announced that it will be unveiling its third quarter financial results on Monday 28th October 2024. This eagerly anticipated announcement is scheduled to occur after market close, ensuring that investors and analysts have the opportunity to gain valuable insights into the company's performance during the quarter.
As per the projections made by financial experts on Wall Street, the organization is expected to announce an estimated $0.94 profit per share for the quarter. Moreover, the firm is likely to disclose a quarterly revenue of $1.33 billion.
Analysts on Wall Street have shared their predictions regarding the annual performance of the company, estimating a total revenue of $5.32 billion. Additionally, they are expecting the company to achieve per share profit of $4.19 for the fiscal year.
The per-share income of $0.86 was highlighted in the company's earnings report for the same quarter of the prior year. This notable figure was achieved due to the company's impressive total revenue of $1.21 billion recorded during that specific period.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $1.11 | +16.8% | 1.30 B | +9.6% |
| Q1 2024 | $1.12 | +27.3% | 1.32 B | +13.4% |
| Q4 2023 | $0.95 | +8.0% | 1.25 B | +9.7% |
| Q3 2023 | $0.86 | +28.4% | 1.21 B | +10.7% |
| Q2 2023 | $0.95 | +6.7% | 1.19 B | -10.8% |
| *Growth on year-over-year basis | ||||
EHC has scheduled a conference call on 29th October 2024 at 10:00 AM eastern time to discuss the third quarter financial results and other related information.
Encompass Health Corporation (EHC) closed Thursday's regular trading session at $94.66, reflecting a 1.05 percent decline. The stock fluctuated between $94.65 and $96.08 during the day, with a volume of 414.10 thousand shares.
